SE0201940D0 - New combination II - Google Patents

New combination II

Info

Publication number
SE0201940D0
SE0201940D0 SE0201940A SE0201940A SE0201940D0 SE 0201940 D0 SE0201940 D0 SE 0201940D0 SE 0201940 A SE0201940 A SE 0201940A SE 0201940 A SE0201940 A SE 0201940A SE 0201940 D0 SE0201940 D0 SE 0201940D0
Authority
SE
Sweden
Prior art keywords
new combination
relates
disease
reflux
thrive
Prior art date
Application number
SE0201940A
Other languages
Swedish (sv)
Inventor
Anders Lehmann
Michael Wrangstadh
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0201940A priority Critical patent/SE0201940D0/en
Publication of SE0201940D0 publication Critical patent/SE0201940D0/en
Priority to ARP030102095A priority patent/AR040203A1/en
Priority to PCT/SE2003/001008 priority patent/WO2004000856A1/en
Priority to TW092116257A priority patent/TW200403059A/en
Priority to AU2003237739A priority patent/AU2003237739A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/04—Sulfinic acids; Esters thereof

Abstract

The present invention relates to a medicament comprising, separately or together, (i) at least one reflux inhibitor; and (ii) at least one imidazopyridine. A further aspect of the invention relates to methods of treatment of gastro-esophageal reflux disease, regurgitation, asthma, failure to thrive and lung disease.
SE0201940A 2002-06-20 2002-06-20 New combination II SE0201940D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0201940A SE0201940D0 (en) 2002-06-20 2002-06-20 New combination II
ARP030102095A AR040203A1 (en) 2002-06-20 2003-06-11 COMBINATION OF A REFLUX INHIBITOR AND AN IMIDAZOPIRIDINE FOR THE TREATMENT OF GERD
PCT/SE2003/001008 WO2004000856A1 (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
TW092116257A TW200403059A (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
AU2003237739A AU2003237739A1 (en) 2002-06-20 2003-06-16 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201940A SE0201940D0 (en) 2002-06-20 2002-06-20 New combination II

Publications (1)

Publication Number Publication Date
SE0201940D0 true SE0201940D0 (en) 2002-06-20

Family

ID=20288298

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201940A SE0201940D0 (en) 2002-06-20 2002-06-20 New combination II

Country Status (5)

Country Link
AR (1) AR040203A1 (en)
AU (1) AU2003237739A1 (en)
SE (1) SE0201940D0 (en)
TW (1) TW200403059A (en)
WO (1) WO2004000856A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1736478B1 (en) 2000-05-26 2015-07-22 IDENIX Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
MXPA05012463A (en) * 2003-05-27 2006-01-30 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility.
WO2005077345A1 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Compounds for the treatment of gastro-esophageal reflux disease
SE0402462D0 (en) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
US7566738B2 (en) 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2006050472A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
US7585996B2 (en) 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (en) 2010-02-01 2012-03-07 Novartis Ag CICLOHEXIL-AMIDA DERIVATIVES AS ANTAGONISTS OF CRF RECEIVERS
AR080055A1 (en) 2010-02-01 2012-03-07 Novartis Ag DERIVATIVES OF PIRAZOLO- [5,1-B] -OXAZOL AS ANTAGONISTS OF THE RECEIVERS OF CRF -1
US8835444B2 (en) 2010-02-02 2014-09-16 Novartis Ag Cyclohexyl amide derivatives as CRF receptor antagonists
UY34094A (en) 2011-05-27 2013-01-03 Novartis Ag DERIVATIVES OF PIPERIDINE 3-ESPIROCYCLIC AS AGRONISTS OF GHRELINE RECEPTORS
PE20142443A1 (en) 2012-05-03 2015-01-28 Novartis Ag SALT OF L-MALATE OF DERIVATIVES OF 2,7-DIAZA-SPIRO [4,5] DEC-7-ILO AND CRYSTALLINE FORMS OF THE SAME AS AGONISTS OF THE GRELIN RECEPTOR

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603408D0 (en) * 1996-09-18 1996-09-18 Astra Ab Medical use
SE9801526D0 (en) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9904508D0 (en) * 1999-12-09 1999-12-09 Astra Ab New compounds
SE9904507D0 (en) * 1999-12-09 1999-12-09 Astra Ab New compounds

Also Published As

Publication number Publication date
AR040203A1 (en) 2005-03-16
WO2004000856A1 (en) 2003-12-31
TW200403059A (en) 2004-03-01
AU2003237739A1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
SE0201940D0 (en) New combination II
ATE408601T1 (en) FREDERICAMYCIN DERIVATIVES
ATE344029T1 (en) TREATING TYPE II DIABETES WITH DIPEPTIDYL PEPTIDASE IV INHIBITORS
ATE461217T1 (en) GLP-1 COMPOUNDS
CY1109240T1 (en) A combination of Valsartan, Amlodipine and Hydrochlorothiazide
ATE508735T1 (en) PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES
NO20052591L (en) Pyridopyrolizine and pyridoindolizine derivatives
CY1110835T1 (en) DIFFINYL PRODUCTS AND THEIR USE IN THE TREATMENT OF USITIS C
TNSN06138A1 (en) INHIBITORS OF THE MUTANT FORM OF KIT
RS52942B (en) Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione
NO20052512L (en) Purine compounds and use deav as cannabinoid receptor ligands
NO20064186L (en) Substituted pyrazoline compositions to reduce blood triglycerides
CY1110669T1 (en) USE OF SULFAMIDI-CONTAINED HYDRO-CYCLOTIC PRODUCERS OF SULFAMIDE
SE0301888D0 (en) New use VII
NO20070608L (en) Use of 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
EA200600223A1 (en) SUBSTITUTED 2-AMINOTHETRALINES FOR THE TREATMENT OF DEPRESSION
EA200701181A1 (en) MEDICINES INTENDED FOR THE TREATMENT OR PREVENTION OF FIBROUS DISEASES
HRP20050439B1 (en) New use of dextran sulfate
CY1110130T1 (en) MORPHOLINE PRODUCTS FOR USE AS DOPAMINE AGONISTS IN THERAPEUTIC DISEASE Therapeutic Treatment I.A.
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
DK1458393T3 (en) Substituted diketopiperazines as oxytocin antagonists
CY1110369T1 (en) NEW COOPERATIVE COMBINATION THAT INCLUDES Roflumilast And Formoterol
BRPI0410467A (en) compositions and methods for the treatment of severe acute respiratory syndrome (SARS)
ATE451934T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RHINITIDES
DE50310038D1 (en) INGREDIENTS OF UROKINASE, THEIR PREPARATION AND USE